Fresenius MedCare: EPS up 8% in 2024

(CercleFinance.com) - Fresenius Medical Care reports 2024 EPS up 8% to E1.
83, and operating profit based on outlook up 18% to E1.81bn, thus reaching the top end of its target range.

At just over E19.3bn, sales of the German dialysis specialist fell by 1% on a reported basis, but rose by 4% on an organic basis. On an outlook basis, sales rose by 2%, in line with annual targets.

For 2025, the group anticipates operating profit growth in the upper 10% to upper 20% range, and in in the low single digit range for revenues, at constant exchange rates and excluding exceptional items.


Copyright (c) 2025 CercleFinance.com. All rights reserved.